We have investigated a group of bacteriocinogenic strains used in the epidemiological investigation of Klebsiella infections. Transfer of plasmids from these strains to laboratory strains allowed the identification of three klebicins which use the cloacin DF13 receptor in Klebsiella, but are of three distinct immunity types. These klebicins use the ferric-aerobactin receptor determined by ColV-K30 in Escherichia coli, which is also used by cloacin DF13. We propose to call them group A klebicins, of immunity types A l , A2 and A3. On the basis of immunity, cloacin DF13 also belongs to the klebicin A1 group.
matings, 5 pl of overnight broth cultures of donor and recipient strains were inoculated into 5 ml LB medium and incubated overnight without shaking, and then plated on selective medium. For plate matings, a streak plate of donor colonies was replicated onto a lawn of recipient cells on LB agar, which was incubated overnight and then replicated onto selective medium.
Transjormation. Cells were transformed as previously described (Chak & James, 1984) . After time for expression, transformed cells were diluted into broth consisting of 1 vol. sterile klebicin extract and 2 vols LB medium, grown overnight with shaking, then plated out to obtain single colonies for klebicin testing.
Klebicin production. The stab/overlay method described for colicins (Ozeki et al., 1962) was used to detect klebicin-producing transformants and transconjugants.
Preparation of klebicin extracts. Klebicinogenic strains were grown to ODss0 0.1 5 4 . 2 with shaking, and then mitomycin C was added to a final concentration of 0.5 yg ml-' . After 4 h of further incubation, chloroform was added and the cultures were shaken for an additional 30 min. After centrifugation at 20000g for 10 min the pellets were discarded. The supernatants, with klebicin activity, were stored at 4 "C and retained activity for at least 4 weeks. They gave clear zones on M5a1, the sensitive control strain, when used undiluted or at a lo-' dilution. Klebicin sensitiuity testing. A 0.1 ml sample of an overnight culture of indicator bacteria in 2.5 mlO*6% Davis agar was overlaid on an LB agar plate. Drops (5 yl) of undiluted klebicin extracts were then spotted on the plate. Clear zones of inhibition after overnight incubation were scored as sensitivity to the klebicin extract. Sensitivity testing was repeated at least three times.
Plasmid preparation and agarose gel electrophoresis. The methods for the preparation of plasmid DNA and electrophoresis have been previously described (Chak & James, 1984) . Table 3 . Immunity tests between representatiue klebicin-producing strains
The Klb+ plasmid present in the strains from which extracts were made is shown in brackets : + , clear zone of inhibition; -, no zone of inhibition; NT, not tested.
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R E S U L T S
Identification of klebicins which use the cloacin DF13 receptor K . pneumoniae strain M5al and derivatives were sensitive to cloacin DF13 determined by pJN73 suggesting that, like Enterobacter cloacae H478 or E. coli K 12 strains carrying ColV-K30, sensitivity was due to the presence of an outer membrane protein which serves as the ferricaerobactin receptor (van Tiel-Menkveld et al., 1981 ; Bindereif et al., 1982; Grewal et al., 1982) . To identify klebicins which use this receptor, the 15 extracts of the Edmondson & Cooke (1979) producer panel were screened for those active on UNF1785 and inactive on cloacin DF13-resistant mutants such as PC901. Six extracts fell into this category (Table 2) , all of which were inactive against E. coli K12 strains, inherently cloacin-resistant due to lack of a receptor, but were active on E. coli K12 strains carrying ColV-K30. Extracts of P1 and P2 were inactive on PC902 which carries pJN73, suggesting that these klebicins are of the same immunity type as cloacin DF13. The extracts of P3, P4, P5 and P8 were active on strain PC902, showing that they contained klebicins of an immunity type different from cloacin DFl3. Klebicinogenic (Klb+) plasmids were transferred from strains P5 and P3 to laboratory strains of K . pneumoniae for further analysis.
Isolation ojpP5a
Plasmid DNA isolated from strain P5 was used to transform UNF5023. One type of Klb+ transformant only was isolated, characterized by PC905 (Table 3) . Like P5, its klebicin was active against UNF1785 but not PC901. However, its klebicin was also inactive against PC902, indicating that pJN73 carries immunity to it. This result was unexpected because PC902 was sensitive to P5 extract. As an indicator PC905 was resistant to all six klebicin extracts and cloacin DF13 and presumably lacked the appropriate receptor. Agarose gel electrophoresis of plasmid DNA isolated from PC905 showed that it carried a 10 kb plasmid, pP5a (Fig. 1) . R64-11 mobilized pP5a from the transformant to UNF801 and transconjugants, like PC907, were obtained which were cross-immune with PC902, confirming that their bacteriocins were of the same immunity type. Sensitivity of both strains to P5 extract showed that this extract contained a second klebicin of a different immunity type. Surprisingly, a plasmid band equivalent to pP5a was not seen on agarose gels of DNA from P5 (Fig. l) , despite several attempts. However, two other plasmids of 7-5 kb and 110 kb were visible, one of which presumably coded for the second klebicin.
Isolation of pP5b
It was considered likely that the plasmid coding for the second klebicin was the 7.5 kb plasmid. The R-plasmid R64-11 was introduced into strain P5 to try to mobilize this small plasmid. (Although P5 has a large and possibly transmissible plasmid, it carried no obvious selectable marker such as antibiotic resistance.) The resulting strain PC904 was mated with UNF8Ol. Several Tcr transconjugants, such as PC908, were obtained, all of which were Klb+ and their klebicin was active on the cloacin-immune strains PC902 and PC907. They were sensitive to cloacin and the pP5a klebicin produced by PC902 and PC907 respectively (Table 2) . Agarose gel electrophoresis of plasmid DNA isolated from strain PC908 showed that this strain contained the 7.5 kb plasmid of strain P5, which we call pPSb, together with R64-11 (Fig. 1) . Strain PC908 was sensitive to extracts prepared from strains PI, P2, P3, P4 and P5 (Table 2) . It was immune to P8 extract, suggesting that the P8 klebicin belonged to the same immunity group as p5b.
Isolation of pP3
An extract of strain P3 was active on UNF5023 strains carrying pP5a or pPSb, or both, indicating that strain P3 produced a klebicin of a third immunity type. In agarose gels of DNA isolated from this strain only one plasmid band, of 13 kb, was visible. R64-11 was used to mobilize this plasmid from PC903 into UNF5023 and Klb+ transconjugants were isolated, i.e. strain PC910. The klebicin produced by PC910 was active on PC902, PC907 and PC908, whilst PC910 was sensitive to the klebicins produced by these strains (Table 3) . Agarose gel electrophoresis showed that PC910, like PC903 (Fig. l) , carried R64-11 and the 13 kb plasmid pP3 which presumably codes for the klebicin of the third immunity type.
Requirement for the ferric-aerobactin receptor of' E. coli The activity of the three klebicins determined by pPSa, pP5b and pP3 was tested against an E. coli K12 strain, PC663, carrying ColV-K30 and PC664 carrying the mutant ColV-K30 plasmid, in which the gene for the ferric-aerobactin receptor is inactivated by Tn801 (Grewal et al., 1982) . All three extracts, active on the former, were inactive on the latter (Table 3) , providing further evidence that this receptor is required presumably for adsorption into sensitive cells.
DISCUSSION
The results presented here show that there is a group of klebicins which apparently require the same receptor as cloacin DF 13. They are inactive on cloacin-resistant mutants of K . pneumoniae which presumably lack this receptor. They are active on E. coli K12 strains carrying ColV-K30, but not if the structural gene for the ferric-aerobactin receptor on this plasmid has been inactivated by transposon mutagenesis. The cloacin (ferric-aerobactin) receptor of Enterobacter cloacae is a 90 kDal outer membrane protein (Oudega et al., 1979) and that determined by ColV-K30 in E. coli K12 is 74 kDal (Grewal et al., 1982) . As yet, we have not identified the relevant receptor of the K. pneumoniae strains used in this study. We predict that it is the ferric-aerobactin receptor in these strains as well.
We have established that there are three immunity types in the group of klebicins we studied, and further immunity types may occur. In the case of the E colicins which use the vitamin B12 receptor of E. coli for adsorption, nine immunity types have been reported (Fredericq, 1956; Males & Stocker, 1982; Cooper & James, 1984) . We will refer to the klebicins reported here as group A klebicins, with Al, A2 and A3 as the immunity types. Thus the klebicin encoded by pP5a is klebicin A1-P5, that by pP5b is klebicin A2-P5, and that by pP3 is klebicin A3-P3. By this convention cloacin DF13 could be referred to as klebicin A1-DF13. The results in Table 2 show that the klebicins produced by strains P1 and P2 belong to the A1 group, and that of P8 belongs to the A2 group. Analysis of strain P4 showed that it is similar to strain P5, having klebicin A 1 and A2 activities (J. Schneider, personal communication). These results imply considerable redundancy in the original typing panel. Transfer of plasmids to laboratory strains, which has proved invaluable in the classification and identification of colicins, has allowed a detailed analysis which is essential in rationalizing the choice of klebicins for a typing panel.
These klebicin plasmids were introduced into M5al derivatives by transformation or by Rplasmid mobilization. The reason why plasmid pP5a is not visible in agarose gels of DNA from strain P5, but is visible in K. pneumoniue M5al derivatives carrying pP5a alone or with pP5b and R64-11 (Fig. l) , is not clear. Perhaps it is present in lower copy number in the genetic background of P5. Transformants with a plasmid preparation of P5 were selected on the basis of immunity to P5 extract, which was higher in klebicin Al-P5 activity than in klebicin A2-P5 activity, and would thus favour pP5a transformants. R-plasmid mobilization of pP5b from PC904 may be favoured over pP5a as it is a smaller plasmid and/or may be present in higher copy number. We have not explored the mobilization frequencies of the two plasmids further. Plasmid pP5a appears to be similar to pClo-DF13 on the basis of restriction mapping. Plasmid pClo-DF13 confers colicin E6 immunity on E. coli K12 (Males & Stocker, 1982) and we have found that pP5a also confers E6 immunity on E. coli K 12. The colicin E6 immunity gene on this
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plasmid is distinct from the klebicin immunity gene. In contrast, pP5b and pP3 confer colicin E3 immunity but not E6 immunity on E. coli K12 (unpublished observation). The relationship between E colicins and A klebicins is intriguing and may be significant in understanding their evolutionary origins.
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